Investor Archive - Page 160 of 170 - Wockhardt

FINANCIAL RESULTS FY12 Q1

Annual report 2011 – 2012

WOCKHARDT RECEIVES TENTATIVE US FDA APPROVAL FOR GENERIC VERSION OF DEPRESSION DRUG CYMBALTA®

WOCKHARDT RECEIVES TENTATIVE US FDA APPROVAL FOR GENERIC VERSION OF PATANOL® OPHTHALMIC SOLUTION

For Quarter-ended Jun 30, 2011

WOCKHARDT LAUNCHES THREE NEW / PRODUCTS IN THREE WEEKS, IN THE UNITED STATES

Annual Results FY 2010 – 11

Financial Results FY 2011 – 12 Q4 (Jan – Mar 2012)

Financial Results FY 2011 – 12 Q3 (Oct – Dec 2011)

WOCKHARDT RECEIVES US FDA APPROVAL FOR GENERIC VERSION OF ARICEPT® TABLETS